Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve standalone unaudited financial results for the quarter and nine months ended On 31st December, 2025.